Quantitative assessment of microstructural damage in paediatric aortic coarctation tissue during benchtop balloon angioplasty and stenting Authors: N Linnane, R D Johnston, D Kenny, C Lally Published: 2026 ABSTRACT AbstractEndovascular stenting of native coarctation of the aorta (CoA) has become the standard treatment for children and young adults due to its less invasive nature and faster recovery times. Despite these advantages, neonatal CoA is still surgically treated, owing to the challenges of vessel growth and limited available stent designs. Plain old balloon angioplasty (POBA) of neonatal coarctation has been used in the past but concern around vessel damage and aneurysm formation has limited its widespread adoption. To-date, stenting has often been preferred over POBA in other anatomies, but little evidence has been gathered to establish the degree of tissue damage during intravascular procedures in neonatal CoA. The aim of this ex vivo study was to perform balloon angioplasty and stenting on neonatal CoA samples harvested from surgery and visualise the deformation under ultrasound guidance. Collagen hybridizing peptide (CHP) was used to assess the level of collagen damage in the tissue following these procedures. The results demonstrate that balloon angioplasty alone is not a viable treatment option for maintaining vessel patency unless very high levels of stretch are achieved to permanently deform the tissue. Five out of six neonatal coarctation samples were successfully stented with no stent failures, showing that stent insertion is a viable option to achieve the desired lumen diameter. Both procedures, however, induced considerable collagen damage. Overall, this study shows that stenting CoA tissue can achieve the desired lumen gain, however, a staged approach to stent expansion may be preferred to reduce collagen damage in the tissue.Keywords: Neonatal aortic coarctation, Collagen hybridizing peptide (CHP), Ultrasound, Coarctation stentingSubject terms: Cardiology, Diseases, Medical research Introduction Coarctation of the aorta (CoA) is reported to have an incidence of 0.3 to 0.6 in 1000 live births, comprising for 5% − 8% of all congenital heart diseases1,2. Technically, it is defined as a narrowing of the aorta, typically located at the insertion of the ductus arteriosus just distal to the left subclavian artery, although it can be located either proximally or distally to the ductus3–5. The narrowing is often discrete but, in some cases, can be a long segment stenosis and/or tortuous3,5. A discrete coarctation can occur in isolation, however it is commonly associated with other congenital heart defects, including bicuspid aortic valve (60%), aortic arch hypoplasia and other arch anomalies (18%), ventricular septal defect (13%), mitral valve abnormalities (8%) and sub-aortic stenosis (6%)3. Historically, CoA was treated with surgical excision and anastomosis to remove the obstruction. However, in recent times, endovascular treatment options, including balloon angioplasty and stent implantation have been described2,6,7. The reason for this alteration in procedure is due to the reported lower procedural risk and shorter recover times associated with endovascular based approaches when compared to surgery5,8,9. Initial reporting into evaluating the local tissue response to percutaneous therapy was by Lock et al. (1982), who harvested seven coarctation specimens at the time of surgery and performed in vitro balloon angioplasty within two hours of harvest. They demonstrated intima and media tears but removal of the obstruction, paving the way for safety and efficacy studies to be undertaken10. Shaddy et al. (1993) performed the first randomised trial of 36 patients comparing balloon angioplasty to surgical treatment for native coarctation of the aorta. It was observed that there was a reduction in the pressure gradient with few complications noted. Furthermore, there was a higher rate of restenosis in the balloon angioplasty group, yet this did not reach statistical significance8. The complications observed such as higher aneurysm formation in the balloon angioplasty group could be explained by Lock et al. (1982), whereby intima and media damage were a necessary compromise for successful pressure gradient reduction10,11. Interestingly, Forbes et al. (2007) reported on a large series of 578 stenting procedures for the treatment of aortic coarctation, demonstrating excellent outcomes, however aortic wall injuries such as aneurysm or dissection was found to occur12. This observation was supported by long term data from the Coarctation of the Aorta Stent Trial (COAST) demonstrating aneurysm formation as late as 3 years post procedure13. Forbes et al. (2007) through the Congenital Cardiovascular Interventional Study Consortium (CCISC) report that higher morbidity and mortality is observed in older patients, likely due to reduced aortic compliance12. Furthermore, the CCISC report followed on from this with a prospective study by Holzer et al. (2010) showing increased wall injury with balloon angioplasty compared to surgery or stenting14. There are multiple other studies which have demonstrated the safety and efficacy of stenting in coarctation of the aorta and this is becoming standard care in many institutions15–22. The issue is that stents used in treatment of CoA are generally “off-label”, with biliary stents being the most commonly used, often resulting in less than optimum outcomes13,23,24. However, it is important to note that there are some promising recent studies looking at developing stents specifically for the treatment of coarctation of the aorta in infants25,26. Although stenting is generally improving patient outcomes, there is always a risk of excessive expansion, where the tissue may be damaged during balloon angioplasty and stenting, leading to possible aneurysm development or aortic dissection12,27–29. A recent study by Cornelissen et al. (2023), also observed that the magnitude of stent indentation is positively correlated to the level of vessel damage, with subsequent neointimal growth observed in histology in rat aorta30. To-date however, no study has quantified the level of microstructural damage specifically in neonatal aortic coarctation tissue during balloon angioplasty and stenting. To assess microstructural damage, collagen hybridizing peptide has been used in a range of tissues to date31–40. CHP is known to be a synthetic peptide with the collagen mimicking glycine-proline-hydroxyproline repeating sequence and has a strong propensity for forming the triple helical structure of collagen39–41. When the collagen is damaged/denatured, the triple helix unravels allowing CHP to bind to reform the triple helix structure. CHP can also be fluorescently labelled enabling this damaged collagen to be located and quantified39–41. The observations in these studies are interesting as balloon angioplasty and stenting can impose high supraphysiological levels of stress and strain within the tissue42–45. Furthermore, it is known through imaging evaluations that there is significant collagen fibre remodelling observed in arterial tissue during stent strut indentation46,47, suggesting significant microstructural changes. However, no study to date, has visualised the level of microstructural damage that could occur within neonatal aortic coarctation tissue when undergoing balloon angioplasty and stenting. In this study, balloon angioplasty and stenting of neonatal aortic coarctations were performed under ultrasound guidance in an in-house benchtop setup to determine the best treatment method for restoring luminal diameter in neonatal CoAs. These samples were then analysed further using the novel collagen hybridizing peptide (CHP) to assess the level of microstructural damage induced during these treatment procedures. Materials and methods In-vivo CoA vessel imaging Echocardiographic images of neonatal aortic coarctation patients were taken to establish the size of the isthmus and descending aorta as Sandovel et al. (2020) recommended that the balloon for angioplasty and stenting should be 2–3 times larger than the isthmus, but not larger than the descending aorta48. As shown in Fig. 1A and B, the suprasternal view was used to isolate the isthmus and the long axis subcostal view was used to visualize the descending aorta, whereby geometric measurements were extracted (yellow lines) and recorded, see Tables 1 and 2. The balloon size was recorded before balloon angioplasty and stenting and the balloon to isthmus ratio was calculated for grouped datasets in our analysis. Echocardiographic images used to take measurements prior to benchtop testing, (A) Suprasternal view where isthmus measurement (yellow line) was taken. (B) Long axis subcostal view where descending aorta measurement at diaphragm (yellow line) was taken. (C) Images of samples 1–5 used for neonatal aortic coarctation balloon angioplasty experiment with Tyshak II® balloon. (D) Images of samples 6–11 used in neonatal aortic coarctation stenting experiment with the Renata MinimaTM stent51. The scale bar is 2 mm in length with respect to each image. Table 1Isthmus and descending aorta measurements taken from echocardiography images of samples 1–5 used for balloon angioplasty experiment. Balloon to isthmus ratio calculated considering balloon size used for expansion of samples.Sample numberIsthmus measurement (mm)Balloon size (mm)Descending aorta measurement (mm)Ratio (balloon/isthmus)11.54.05.72.6722.84.04.11.4332.25.04.82.2743.85.04.51.3253.96.06.71.54 Isthmus and descending aorta measurements taken from echocardiography images of samples 1–5 used for balloon angioplasty experiment. Balloon to isthmus ratio calculated considering balloon size used for expansion of samples. Table 2Isthmus and descending aorta measurements taken from echocardiography images of samples 6–11 used for aortic coarctation stenting experiment. Balloon to isthmus ratio calculated considering balloon size used for expansion of samples.Sample numberIsthmus measurement (mm)Balloon size (mm)Descending aorta measurement (mm)Ratio (balloon/isthmus)61.96.04.93.1672.96.06.12.0782.16.05.12.8692.26.06.12.73101.96.04.53.16111.36.07.14.62 Isthmus and descending aorta measurements taken from echocardiography images of samples 6–11 used for aortic coarctation stenting experiment. Balloon to isthmus ratio calculated considering balloon size used for expansion of samples. Tissue specimen collection and preparation for testing Neonatal aortic coarctation samples were obtained from 11 patients at Children’s Health Ireland at Crumlin, Ireland. Ethical approval for samples collection was obtained from research and ethics board at Children’s Health Ireland In accordance with the 1964 declaration of Helsinki and its later amendments with informed consent was obtained from parents/legal guardians from all participants. Patients were previously identified as having a coarctation (CoA) by the treating medical team, separate to the research team and a decision made to proceed to surgery, whereby each patient underwent an extended end to end repair of the aortic coarctation. Using previously established protocols for atherosclerotic plaque tissue49, on the day of surgery, samples were collected from theatre upon their immediate removal and stored in phosphate buffered saline (PBS) and stored for transport at room temperature. Samples were initially photographed and subsequently stored into tissue freezing medium (TFM), comprising of RPM-60 Media, 1.8 M DMSO and 0.1 M sucrose and placed into a Mr. Frosty cryosystem containing 2-proponol and cryopreserved at −80℃ within 6 h of harvesting. After a period of 12 h, the samples were removed from the Mr Frosty cryosystem and left at −80℃ until the day of stent implantation. It has been established in the literature that this cryopreservation process has a non-significant effect on the tissues’ mechanical properties49,50. On the day of testing, the samples were defrosted in PBS at ambient temperature, ready for placement in our benchtop setup. A small section of <1 mm was cut to act as a control for the level of CHP fluorescence in each CoA tissue sample. 5 samples were assigned to undergo balloon angioplasty, see Fig. 1C, and 6 samples were assigned to undergo stenting with cobalt chromium Renata Minima™ stents51, see Fig. 1D. The Renata Minima™ stent was chosen as it has been FDA approved for the staged expansion in neonates and infants as unlike conventional stents, it has been engineered to crimp to <2 mm, expanded to 5.1 mm and permit planned re-dilation up to diameters of 24 mm26,52. Stented neonatal coarctation sample 8 showing more pronounced indentation of regions of ductal tissue (right side) in comparison to the healthier aortic tissue (left side). Yellow arrows highlight area of stent indentation. Bench-top CoA balloon angioplasty and stenting For our experiments, a custom-made water bath was designed in Solidworks (Dassault Systèmes Simulia Corp., Rhode Island, USA), see Fig. 2A, and fabricated in polylactic acid (PLA) filament using a Prusa i3 MK3S+ 3D printer (Prusa Research, Prague, Czechia). The bath was designed to ensure it could accommodate a 12L4 linear array ultrasound probe from a SIEMENS ACUSON S2000™ ultrasound system. To ensure a watertight system, 100% infill was used during printing with the outside of the water bath coated in epoxy resin to ensure no leakage of the PBS during testing. To allow for the introduction of the 0.014” SION® blue coronary wire (Asahi Intec, Japan) and balloons, cable glands were attached on the end of the bath as shown in Fig. 2B. After the relevant apparatus were introduced for the test, these cable glands were tightened along with a Tuohy-Borst, to ensure suspension of the sample on the coronary wire and allowing for the Encore™ inflator device (Boston Scientific, Galway, Ireland) to inflate the balloon whilst ensuring no leakages occurred. In our balloon angioplasty experiments, a 4 mm (nominal pressure ≈ 4.5 atm), 5 mm (nominal pressure ≈ 4.5 atm) and 6 mm (nominal pressure ≈ 3.5 atm) diameter, 30 mm length Tyshak II® balloons (Numed, Hopkinton, NY, USA) were used. For the stenting experiments, the Minima™ stents (Renata Medical, California, USA) were mounted on a 6 × 30 mm (nominal pressure ≈ 6 atm) Sterling™ balloon (Boston Scientific, Galway, Ireland). After filling of the water bath with PBS, the 12L4 ultrasound probe was positioned at the top of the bath to obtain cross sectional views of the aortic coarctation sample with the probe set at frequency of 9 MHz, as shown in Fig. 2C. Continuous video feedback was obtained during the ultrasound acquisition, allowing for imaging of the aortic coarctation in the initial state and after balloon angioplasty and stenting. (A) Custom made 3D printed water bath design compatible with ultrasound 12L4 probe. (B) Plan view schematic and photograph of the experimental setup showing neonatal aortic coarctation sample suspended on coronary wire before PBS fill. (C) Final setup with ultrasound 12L4 probe in position over the neonatal aortic coarctation sample. Histological analysis Balloon expanded and stented neonatal aortic coarctation samples were fixed in 10% formalin for a period of 24 h. Once fixed, samples were then dehydrated (Leica TP1020, Semi-enclosed benchtop tissue processor, Germany) and embedded in paraffin wax blocks. Following this, 7 μm cross sections were cut from the blocks using C35 microtome blades and subsequently floated on distilled water at 37 °C before mounting on glass slides. The slides were left to dry for a period and staining was then performed using a Leica Autostainer (Leica ST5010, Autostainer XL, Germany), that also performed deparaffinization and rehydration of the samples. Histological stains included Haematoxylin and Eosin (H&E), Picrosirius red (PSR) with polarized light microscopy (PLM) and Verhoeff’s, to visualize the cellular content, collagen, and elastin content, respectively. Once stained, slides were then cover slipped using a coverslipper (Leica CV5030, Automated Coverslipper Machine, Germany) in which DPX mountant was used as the mounting agent. Brightfield imaging of all stained samples was performed on an Aperio CS2 microscope with ImageScope software V12.3 (Leica Biosystems Imaging, Inc., Vista, California). Polarized light microscopy (PLM) was also performed on the picrosirius red (PSR) stained samples using an Olympus BX41 microscope with Ocular V2.0 software (Teledyne Photometrics, Tuscon, Arizona). Two PLM images were taken for each histological slice, with images 45° to each other, and the exposure time kept consistent across all samples49,53. Collagen hybridizing peptide (F-CHP) Collagen hybridizing peptide was procured from 3-Helix (3 Helix, Inc., Salt Lake City, UT) for the assessment of microstructural damage within the neonatal aortic coarctation under balloon angioplasty and stenting. F-CHP, the type used in this study incorporates a fluorescein component which allows for fluorescence to occur when the F-CHP binds with the collagen and is subsequently excited53. To setup samples for F-CHP staining after testing, the samples were processed using standard histological approaches as stated previously. Before F-CHP staining, the slides were rehydrated using a standard protocol of xylene to 100% alcohol to water. F-CHP was diluted in 1 ml of PBS and centrifuged making a 100 µM stock solution, which was diluted further to a concentration of 20 µM as recommended for staining slides31,54 On the day of staining, the F-CHP was heated to 80 °C for 5 min, cooled rapidly to room temperature and then administered onto samples on glass slides. Stained slides were kept at 4 °C for 24 h for sufficient binding to occur. For cover slipping, residual F-CHP was rinsed off the samples with PBS and a coverslip was applied with Mowiol mounting agent containing DABCO (1,4 diazabicyclo [2.2.2] octane). Once cover slipped, fluorescent imaging of F-CHP stained aortic coarctation samples was performed in a dark room using an Olympus BX51 upright microscope (Olympus Lifescience Solutions). For F-CHP, an excitation wavelength of 495 nm is used with an emission wavelength of 512 nm. Importantly, the exposure time for the images were kept constant for the fluorescent level across all samples so they were comparable. For the ballooned and stented neonatal tissue, all samples had an exposure of 909.1 ms during imaging. For localized assessment of the fluorescent intensities observed in our F-CHP-stained samples, the software ImageJ55 was used to extract the mean intensities from the control, ballooned and stented samples, respectively. Statistical analysis Statistical analyses were performed using GraphPad Prism 10 (GraphPad Software LLC). Normally distributed data was analysed with unpaired t-test. Non-normally distributed data was analysed using Mann-Whitney test. Results Balloon angioplasty of neonatal aortic coarctation samples Samples 1 and 2 were inflated to 4 mm and once deflated there was clear recoil of the tissue, enclosing the lumen diameter, and no obvious permanent deformation was observable once the balloon was deflated, as shown by Fig. 3A. Similar results were observed for samples 3 and 4, inflated to 5 mm diameter, with full recoil occurring after balloon deflation, see Fig. 3B. After being inflated to 6 mm, however, Sample 5 showed some level of permanent luminal opening after balloon deflation, see Fig. 3C. Geometric measurements support visual observations, with little change observed in 4 mm expanded samples (2.1 mm to 2.4 mm and 0.6 mm to 0.8 mm) and 5 mm expanded samples (0.6 mm to 0.7 mm and 1.1 mm to 1.2 mm), and the 6 mm expanded sample showing a larger lumen diameter then the original diameter (6.7 mm to 4.7 mm). Overall, these observations would suggest that significant levels of vessel deformation/stretch are required after balloon angioplasty to maintain lumen gain (Table 3). Ultrasound images of the balloon angioplasty experiment with balloon expanded to (A) 4 mm, (B) 5 mm and (C) 6 mm, respectively, depending on the isthmus to the descending aorta ratio. Balloon angioplasty experiment images shown represent (i) Original sample (ii) Balloon inflation showing clear opening of the tissue (iii) Balloon deflation showing recoil of the tissue. All samples show collapse of the lumen diameter except for the 6 mm case, where significant permanent change is observed, post-balloon deflation. Scale bar = 2 mm. Table 3Ballooned neonatal sample measurements of lumen diameter before and after ballooning.Sample numberMaximum balloon diameter (mm)Diameter before ballooning (mm)Diameter after ballooning (mm)Percent expansion (%)14.02.12.414.324.00.60.833.335.00.60.716.745.01.11.29.156.04.76.742.6 Ballooned neonatal sample measurements of lumen diameter before and after ballooning. Deployment of stent within neonatal aortic coarctation samples In the stenting experiment, the Minima™ stents were successfully deployed into 5 out of 6 neonatal aortic coarctation samples, with sample 10 rupturing during the stent inflation process and not reaching the final 6 mm diameter. As shown in Fig. 4, the result of the 5 successfully stented samples looked similar to the balloon angioplasty experiment, except with full opening of the neonatal aortic coarctation after balloon deflation, and little or no tissue recoil. During the entire procedure, the stent can be visualized under ultrasound imaging with clear stuts being visualized during balloon expansion and deflation. The Renata Minima™ stent performed as expected, with no failure of the stents during this procedure. Ultrasound image of stenting procedure of neonatal aortic coarctation using Renata Minima™ stents expanded to 6 mm, (i) Original, (ii) Balloon inflation showing clear opening of the tissue with visible stent struts, (iii) Balloon deflation and stent maintaining its diameter. Scale bar = 2 mm. Histological observations of ballooned and stented aortic coarctation samples. Our histological observations confirm the results seen in Johnston & Linnane et al. (2024)56 showing neonatal aortic coarctation tissue to be highly heterogenous. It has collagen and elastin rich areas typical of aortic regions, and areas with an absence of structured collagen and elastin more typical of ductal tissue, as shown in Fig. 5A and B. An interesting observation can be seen in stented sample 10 which failed during balloon expansion; there is ductal tissue propogating through the entire thickness of the sample where failure is observed. Histological assessment of neonatal aortic coarctation (A) Balloon angioplasty samples (B) Stented samples (i) Haematoxylin and Eosin (H&E) (ii) Picrosirius red (PS-red) (iii) Polarized light microscopy (iv) Verhoeff elastin (VE). Scale bars (Black = 1 mm, White = 250 μm). Locations of high ductal tissue volume appear to have permanent stent indentations (yellow arrows) whilst the more aortic type regions show more recoil in comparison, see Fig. 6. Collagen hybridizing peptide of ballooned and stented aortic coarctation samples. F-CHP quantification shown in Fig. 7A demonstrates that there is an increase in the fluorescence when comparing the ballooned neonatal aortic coarctation samples to their respective control group. Statistical analysis in Fig. 7B shows the mean fluorescence is significantly different in control samples compared to ballooned samples, suggesting collagen damage is occurring within the tissue due to balloon expansion. To understand why this mean fluorescence is higher in the ballooned group compared to the control group, the isthmus balloon ratio was used to group samples and investigate the stretch imposed on the tissue during balloon expansion. Figure 7C shows that samples which are stretched further (Isthmus Ratio > 2) due to balloon inflation show a significantly higher mean F-CHP fluorescence than less stretched samples (Isthmus Ratio < 2), demonstrating that there is increased collagen damage at higher strains. (A) F-CHP images of controls ((i) and (iii)) and representative ballooned samples ((ii) and (iv)) showing visible increase in the fluorescence intensity when samples have been ballooned. Scale bar = 50 μm. (B) Unpaired t-test showing significant difference in the mean intensity between control and ballooned samples (P < 0.001). (C) Mean fluorescence observed in ballooned samples when sorted into groups with Isthmus to Balloon Ratio greater than 2 and less than 2. Visually, the F-CHP fluorescence in our stented neonatal aortic coarctation samples looks significantly brighter than the controls and balloon expanded neonatal aortic coarctation samples shown in Fig. 6A, see Fig. 8A. A major difference is that there are clear depth varying stent strut indentations (yellow arrows) on the tissue when compared to the ballooned samples, supporting the histological observation of the variable microstructural composition. Similar to the ballooned neonatal aortic coarctation samples, there is a statistically significant increase in the mean fluorescence in the stented samples versus the control samples, see Fig. 8B. Therefore, due to the tissue experiencing higher strain in stent expansion, there is higher F-CHP fluorescence suggesting further damage to collagen during this procedure, see Fig. 8C. (A) F-CHP images of stented neonatal aortic coarctation samples with observable stent indentations (yellow lines). Clear variation in fluorescence throughout the tissue. Scale bar = 50 μm. (B) Unpaired t-test showing significant difference between mean fluorescence of control and stented neonatal aortic coarctation, and (C) Mean fluorescence observed in stented neonatal aortic coarctation samples when sorted into grouping with Isthmus to Balloon Ratio greater than 2 and less than 2 (P < 0.001). Like the results observed in Fig. 6, stenting in locations of high ductal tissue volume indents the sample whilst the healthier region shows more recoil in comparison, see Fig. 9. An interesting observation is the variability in fluorescence observed within the sample in which the healthier side shows a higher intensity (red arrows) on the more luminal side with little indentation (yellow arrows), shown by Fig. 9A. Meanwhile on the higher ductal volume side it is observed there is significant indentation (yellow arrows) of the stent within the tissue, with higher fluorescence then observed in the healthier tissue present through the thickness (red arrows), see Fig. 9B. F-CHP of stented neonatal aortic coarctation sample 8 showing more pronounced indentation of region of ductal tissue (right side) in comparison to the healthier aortic component (left side). Yellow arrows highlight area of stent indentation with red arrows highlighting the areas of higher fluorescence in healthier regions of the tissue. As demonstrated histologically in Fig. 10A, neonatal aortic coarctation samples exhibit considerable microstructural variation, with variability observed in both elastin and collagen content. When the samples are stented, F-CHP can identify this variable structure along with quantifying specific regions within the tissue subjected to higher levels of stretch and therefore collagen damage. Figure 10B shows a low intensity fluorescence distribution at the highly indented regions (yellow arrow) in more distinctly ductal tissue. An increased fluorescence intensity distribution is then observed once the region of interest is in the healthier load bearing region of the tissue, which is collagen and elastin rich. Regional specific assessment of F-CHP fluorescence in stented neonatal aortic coarctation samples; (A) Histological overview with (i) H&E, (ii) PS red, (iii) PLM and (iv) VE, (B) Regional assessment with fluorescent intensity histograms showing varied distribution throughout the sample and highly localized damage. Discussion It has been well documented from histological studies that neonatal aortic coarctation tissue lacks elastic laminae57–60. This is thought to play a role in the limited capability for the tissue to undergo stretch in response to device interventions. Our histological results from ballooned and stented native aortic coarctations agree with those previous studies and our previous study56, where it is clearly demonstrated that there is a non-consistent and reduced number of elastic laminae in part of the neonatal aortic coarctation specimens. It has been established that collagen is a key load bearing constituent in arterial vessels61–65 and it is important to note that from this work there is also a paucity of collagen present within regions of CoAs. Overall, there is a striking difference between the CoA tissue, likely originating from ductal arteriosus, and the surrounding aortic tissue which has a healthier microstructure which is rich in both collagen and elastin. Whether this healthier tissue is comparable, in terms of collagen and elastin content, to healthy aortic tissue is still unknown. Regardless, at the coarctation site where the lumen of the vessel was narrowest, the cause of the narrowing was due to tissue similar to ductal arteriosus being present, rather than thickened aorta. The first aim of this study was to investigate the neonatal coarctation response to percutaneous treatment options such as balloon angioplasty and/or stent insertion. It has been noted in the literature that balloon angioplasty has largely gone out of favour with the advent of a broad range of stenting options due to the need to create intimal and medial tears to achieve lumen gain66,67. As outlined in our histological results, the ductus arteriosus tissue seen in the CoA specimens has little elastin or collagen and thus this would indicate very little structural integrity. This was clearly demonstrated in the balloon angioplasty experiments where ultrasound images show the balloon clearly and easily compresses the ductal tissue, but once deflated the lumen closes over again. This suggests that the ductal tissue cannot be permanently deformed without also deforming the aortic tissue, and sufficient lumen gain cannot be achieved otherwise. When using a larger balloon (6 mm), the aortic tissue clearly undergoes more stretch and deformation leading to the lumen remaining patent even after balloon deflation (4.7 mm to 6.7 mm), even with significant tissue recoil. Although these experiments are limited by the lack of physiological blood pressure which arguably may have maintained some lumen gain, it is observed that unless the tissue is stretched well beyond supraphysiological levels, little lumen gain will be achieved by angioplasty alone. This justifies the move to performing stenting of the CoA. In our stenting experiments, it was observed, in 5 out of the 6 cases, that the Renata Minima™ stent opened the vessel to the desired lumen diameter. This supports previous observations in an animal study showing that the Minima™ can achieve the target lumen diameter26. In addition, no stent failures were observed in all cases, demonstrating the Minima™ stent’s structural integrity and the feasibility of implanting it in neonatal aortic coarctations. It was observed from our histological results that sample 10, which failed during stenting, had high ductal tissue volume when compared to other samples and that failure occurred at the site where the ductal tissue was present through the entire thickness of the tissue. This is an interesting observation and suggests an alternative stenting approach should be utilized to accommodate this variable microstructure and ensure that failure does not occur. A recent study by Cornelissen et al. (2023) showed the extent of stent indentation is associated with tissue damage. Using optical coherence tomography (OCT), the authors quantified stent strut indentation and correlated this to histological damage scores30. This approach is promising and could be adapted for use in stenting procedures. As shown in the current study and our previous study56, ductal tissue is readily compressible and readily indents with stent implantation. OCT could be utilized during stenting to assess the amount of ductal tissue present within the coarctation region. This would enable controlled, stepwise stent expansion to minimize the indentation of healthy aortic tissue, reduce vessel damage and obtain the desired lumen diameter. The second aim of this study was to assess the level of microstructural damage in neonatal aortic coarctation when undergoing balloon angioplasty and stenting. The results clearly demonstrate an increase in the level of damage, via CHP-fluorescence, between tested samples (ballooned and stented) and controls, which indicates collagen damage during these procedures. Furthermore, when comparing the stented tissue to the ballooned cases, increased vessel stretches induced higher F-CHP fluorescent intensities, indicating higher collagen damage in the tissue. This increased fluorescence with increased stretching of the tissue agrees with previous studies such as Converse et al. (2017), Zitnay et al. (2017) and Anderl et al. (2023)35,37,41. A key observation from our study is that the varying fluorescent intensities corresponds to differences in the underlying tissue composition; certain regions of high stent strut indentation show lower levels of fluorescent intensity when compared to regions with low stent strut indentation due to the low collagen & elastin content within the compressible ductal-like tissue, with the opposite being observed for “healthier” regions of the tissue. This allows F-CHP to be used not only as a marker for collagen damage, but as a tool to identify variations in tissue microstructure and assess pre-existing tissue integrity prior to intervention. These insights support the potential for developing patient specific stents to be designed to achieve optimum lumen expansion while minimizing vessel damage. Although F-F-CHP has its limitations, it is evident that increased levels of stretch leads to higher fluorescence, indicating greater collagen damage. This excessive tissue stretching, and higher collagen damage may increase the long-term risk of aneurysm formation. This aligns with findings in the literature, whereby balloon angioplasty is associated with higher aneurysm rate compared to surgical repair or stent placement66, likely due to the intimal and medial damage required to achieve sufficient lumen expansion during ballooning. Since lumen gain is the primary objective of percutaneous interventions, the F-CHP results indicate that direct inflation to the maximum diameter with stent deployment will induce collagen damage during such procedures. Therefore, a staged stenting approach may provide better outcomes by minimizing tissue stretch at each stage, reducing initial collagen damage, and allowing for tissue remodelling, which could ultimately lower aneurysm risk. There are some limitations to this study that should be mentioned. Firstly, the neonatal aortic coarctation tissue that underwent either balloon angioplasty and stenting was in an unloaded configuration, without physiological blood pressure and with different balloons to achieve the required vessel diameters. The benchtop setup could be amended to incorporate a pump system to replicate this blood pressure change in the vessel and using the same balloon for all procedures to improve consistency is of interest in future studies to assess initial damage and damage accumulation over time. Secondly, recent studies have been looking at the potential of patient specific stents in treatment of CoA68, yet the Minima™ stent used here is not patient specific. Future work aims to manufacture bespoke stent designs using 3D printing and an optimization approach to minimize the vessel stress whilst achieving the target lumen diameter. Lastly, stents were expanded straight to 6 mm in our stenting experiment, with the same stent used in each test. Future work will look at different deployment strategies in combination with different stent designs to establish the best combination that achieves the desired lumen diameter whilst reducing the level of tissue damage during the procedure. Conclusions Neonatal aortic coarctation is a heterogenous disease with tissue samples demonstrating highly variable microstructural composition. Performing balloon angioplasty alone is not sufficient to achieve the desired lumen gain, with tissue recoil causing collapse of the lumen diameter post-balloon deflation. The Minima™ stent can be successfully deployed to stent neonatal aortic coarctation tissue and achieve the desired lumen diameter, although there is increased collagen damage observed in doing this. This work suggests that future stenting procedures should consider the tissue’s microstructural composition before treatment and implement an incremental deployment strategy to optimize stenting outcomes and reduce microstructural damage and associated aneurysm risk. Acknowledgements The authors would like to thank Dr Evan Zahn, Eason Abbott and Dustin Armer from Renata Medical for providing the MinimaTM stents used in this study. The authors would like to acknowledge the Cardiothoracic Surgical team, especially, Mr Jonathan McGuinness, Prof. Lars Nolke and Prof. Mark Redmond, in Children’s Health Ireland at Crumlin for aiding in obtaining the neonatal coarctation samples for tissue testing and CHP analysis. Author contributions All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [N.L and R.D.J] with interpretation of results performed by [N.L, R.D.J and C.L]. The first draft of the manuscript was written by [N.L and R.D.J] and all authors commented on previous versions of the manuscript [N.L, R.D.J, D.K and C.L]. Supervision was provided by [C.L] All authors read and approved the final manuscript. Funding Research was supported by the StAR MD Program in the RCSI incorporating the Beacon Hospital, Dublin; and by a research grant from Research Ireland (RI) under the grant number 12/RC/2278_2. Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethical approval Ethical approval for obtaining the samples and imaging used in this study was obtained from the research and ethics board of Children’s Health Ireland. Informed consent was obtained from the parents/legal guardians of all patients for the tissue samples used in this study. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. N. Linnane and R. D. Johnston contributed equally to this work. References Associated Data Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.